A Covance Inc. (CVD) investor contends in a lawsuit that the drug-testing company’s board erred in relying on what the shareholder called Goldman Sachs Group Inc. (GS)’s conflict-tainted advice in accepting a $6.1 billion takeover offer from Laboratory Corp. of America Holdings.
Covance’s directors shouldn’t have hired Goldman Sachs as its financial adviser for LabCorp’s more than $105-a-share offer because the investment firm already represented another company Covance was considering acquiring, the investor said in a Delaware Chancery Court lawsuit. That created a conflict of interest, the shareholder alleged.
Hey, check out all the research scientist jobs. Post your resume today!
Covance’s directors shouldn’t have hired Goldman Sachs as its financial adviser for LabCorp’s more than $105-a-share offer because the investment firm already represented another company Covance was considering acquiring, the investor said in a Delaware Chancery Court lawsuit. That created a conflict of interest, the shareholder alleged.
Hey, check out all the research scientist jobs. Post your resume today!
